Addus HomeCare Corporation Stock Price and Value Analysis

Addus HomeCare Corporation (NasdaqGS:ADUS) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Addus HomeCare Corporation to reach your target.

Target type

ADUS Free Cash Flow Trend

Free Cash Flow trendline for ADUS
Free Cash Flow trendline for Addus HomeCare Corporation
CSV

Based on historical returns, we believe that Addus HomeCare Corporation can grow its free cash at a rate of about 7%. That's positive!

AdvantagesDisadvantagesNeutral
  • This company is making money at a decent rate.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company pays no dividend.

Inside the ADUS Numbers

ADUS Price
(Addus HomeCare Corporation stock price per share)
$122.50
[?] ADUS Fair Price
(based on intrinsic value)
$67.20
[?] ADUS Safety Price (based on a variable margin of safety) $40.32
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 1% higher than other Healthcare stocks
[?] PE Ratio versus Industry 15% lower than other Home Health Care stocks
[?] Cash Yield 0.39%
[?] Free Cash Flow Jitter 59%

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

Recent Insider Activity

Open-market buys and sells reported by Addus HomeCare Corporation's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.

Date Insider Type Shares Price
2025-06-16 Stevenson Roberton James (EVP & Chief HR Officer) Sell 228 $112.99
2025-06-10 TUCKER DAVID W. (EVP / Chief Strategy Officer) Sell 2,403 $115.43
2025-05-27 WATTENBARGER MICHAEL D. (EVP/Chief Information Officer) Sell 2,045 $115.00
2025-04-21 BLESSING CLIFF DONALD (EVP/Chief Development Officer) Sell 178 $101.17
2025-03-03 RAINES MONICA (EVP/CCO and Quality Officer) Sell 237 $96.23
2025-02-25 GAFFNEY SEAN (EVP / Chief Legal Officer) Sell 479 $99.84
2025-02-25 POFF BRIAN (EVP/Chief Financial Officer) Sell 2,304 $99.88
2025-02-25 BICKHAM W BRADLEY (President and COO) Sell 2,444 $99.74
2025-02-25 WATTENBARGER MICHAEL D. (EVP/Chief Information Officer) Sell 343 $99.71
2025-02-25 Stevenson Roberton James (EVP & Chief HR Officer) Sell 308 $99.90

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 995,141 shares shorted. With 17,729,387 shares available for purchase and an average trading volume over the past 10 trading days of 215,830, it would take at least 4.6 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2009 1468328 -9.6
2010 1468328 10.1
2011 1468328 15.3
2012 1468328 14.7
2013 1468328 26.6
2014 1468328 5.3
2015 1468328 2.1
2016 1468328 -3
2017 1468328 50
2018 1468328 29.6
2019 1468328 8.5
2020 1468328 105
2021 1468328 34.5
2022 1468328 99.2
2023 1468328 105
2024 1468328 109
2025 1468328 104

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 16 fiscal years from 2009 to 2025 with positive net income, operating cash flow totaled $747 million against net income of $482 million, or 1.55 times. Net income was negative in 1 of the 17 years, and those years are left out of the ratio.

In 2025, operating cash flow was 1.16 times net income, compared with 0.18 times for the earliest three years (2009 to 2011).

In 2025, capital expenditures were $7.7 million, 6.9% of operating cash flow of $112 million, which leaves an estimated $104 million after capex. Across the 15 years with reported capex, it averaged 8.7% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2009 3.6 -8.9 0.7 -2.48
2010 6 10.7 0.6 1.78
2011 -2 15.9 0.6 n/a
2012 7.6 15.4 1.1 2.02
2013 19.1 27.4 0.9 1.43
2014 12.2 7 5.3 0.57
2015 11.6 4.1 2.2 0.35
2016 12.2 -0.7 1.7 -0.06
2017 12 52.8 3.6 4.41
2018 16.4 33.2 5.3 2.02
2019 25.2 12 4.6 0.48
2020 33.1 109 6.8 3.30
2021 45.1 39.5 4.6 0.88
2022 46 105 8.3 2.28
2023 62.5 112 9.5 1.80
2024 73.6 116 6 1.58
2025 95.9 112 7.7 1.16

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $401 million in 2016 and $1,423 million in 2025, a compound annual growth rate of 15.1% over 9 years.

Revenue rose 23.2% from 2024 to 2025.

Our estimated free cash flow was $104 million in 2025, 7.3% of revenue. In 2016 the estimated margin was negative 0.7%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2016 401 -3 -0.7%
2017 426 50 11.7%
2018 517 29.6 5.7%
2019 649 8.5 1.3%
2020 765 105 13.7%
2021 864 34.5 4.0%
2022 951 99.2 10.4%
2023 1,059 105 10.0%
2024 1,155 109 9.5%
2025 1,423 104 7.3%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2024, cash and equivalents were $98.9 million against total liabilities of $442 million, or 22.4% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 24.5% of total assets in 2025, compared with 47.2% in 2010, a decrease of 22.7 percentage points.

Stockholders equity was $1,085 million in 2025, compared with $88.1 million in 2010, a rise of 1132.0%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 8.1% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2010 167 0.8 78.8 88.1
2011 155 2 68.3 86.4
2012 150 1.7 55.4 94.4
2013 164 15.6 50.1 114
2014 181 13.4 52.8 127
2015 186 4.1 44.2 142
2016 230 8 75.2 155
2017 272 53.8 101 170
2018 348 70.4 79.6 268
2019 637 112 161 476
2020 893 145 374 519
2021 948 169 373 574
2022 938 80 304 634
2023 1,024 64.8 318 707
2024 1,413 98.9 442 970
2025 1,437 n/a 352 1,085

What the Price Implies

How to read this: discounted cash flow, intrinsic value.

At today's price of $122.50, our model's value equals that price if free cash flow grows an average of 34.4 percent a year over the 10 projection years. Our model assumes 7.0 percent a year for this stock, so the price implies growth of 34.4 percent, which is above the 7.0 percent our model assumes. This is the growth the price implies under our model, not a forecast of growth or a price target.

At 34.4 percent a year, free cash flow would grow about 19.2 times over the 10 years.

The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.

The model starts from the company's average free cash flow of $8.8 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.

The baseline is the company's average free cash flow, and cyclical companies can mislead it.

CasePrice per shareAverage annual free cash flow growth
20 percent below the current price $98.00 27.5%
Current price $122.50 34.4%
20 percent above the current price $147.00 39.2%
Our model (stored fair price) $67.20 7.0%

Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.

Price Versus Our Estimated Value

Addus HomeCare Corporation is priced at $122.50, above our fair value estimate of $67.20 and its safe value of $40.32.

Addus HomeCare Corporation reported positive free cash flow in 15 of the 17 fiscal years we have from its current SEC filer.

Average free cash flow over the last three years of data was $106 million, and across the first three years it was $5.3 million; over the period it rose sharply.

Free cash flow is volatile from year to year, with a variability measure of 59%.

These numbers change when new filings or prices arrive, so treat this page as a snapshot and check the company's own filings.

We do not have a dividend yield for Addus HomeCare Corporation.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 1% above the average for stocks in the Healthcare sector.

Its trailing P/E ratio is 15% below the average for stocks in the Home Health Care industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1468328.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow was negative in 2 of the 17 years we have.
  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-20
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: ADUS annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in ADUS

Does Addus HomeCare Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: ADUS

This example shows how we apply the Trendshare checklist to ADUS: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 122.50
    • Market cap: $2.3B
    • EPS: 6.01
  2. Step 2 — Valuation checks

    • P/E: 20.383
    • FCF yield: 0.4%
    • Date checked: Nov 20, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.